| |
| |
|
| Insider
Information: |
Henneman John B III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
263,813 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,787,444 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
263,813 |
|
|
| Total
Value |
$3,787,444 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -27.9%
|
-30.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Integra Lifesciences Holdings Corp |
IART |
CorpVP, CAO |
2014-08-25 |
34,159 |
2003-07-14 |
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Chief Administrative O... |
2018-10-01 |
55,052 |
2014-10-01 |
0 |
Premium* |
|
|
Seaspine Holdings Corp |
SPNE |
Director |
2023-01-05 |
0 |
2016-06-07 |
0 |
Premium* |
|
|
R1 RCM Inc |
ACHI |
Director |
2022-06-21 |
0 |
2016-08-16 |
0 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-03-13 |
8,139 |
2019-10-07 |
0 |
Premium* |
|
|
Anika Therapeutics Inc |
ANIK |
Director |
2023-06-14 |
29,936 |
2020-09-03 |
0 |
Premium* |
|
|
R1 Rcm Inc |
RCM |
Director |
2024-05-23 |
87,765 |
2022-06-21 |
0 |
Premium* |
|
|
Orthofix International N.V. |
OFIX |
Director |
2023-01-05 |
48,762 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2009-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
100,000 |
132,078 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2023-01-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(82,654) |
0 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2010-11-02 |
4 |
S |
$42.93 |
$3,031,393 |
D/D |
(70,609) |
89,748 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2010-11-02 |
4 |
OE |
$30.25 |
$2,135,922 |
D/D |
70,609 |
160,357 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2010-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
62,710 |
147,134 |
0 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2022-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
60,790 |
60,790 |
0 |
- |
|
| ACHI |
R1 RCM Inc |
Director |
– • – |
2022-06-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,751) |
0 |
0 |
- |
|
| ACHI |
R1 RCM Inc |
Director |
– • – |
2016-08-16 |
4 |
B |
$1.77 |
$90,098 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2023-08-08 |
4 |
OE |
$2.61 |
$130,500 |
D/D |
50,000 |
122,114 |
0 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2023-08-08 |
4 |
S |
$17.17 |
$858,650 |
D/D |
(50,000) |
72,114 |
0 |
% |
|
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2009-01-02 |
4 |
D |
$35.57 |
$1,616,657 |
D/D |
(45,450) |
86,628 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2014-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,789 |
40,789 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2011-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
38,507 |
72,149 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP, CAO and Acting CFO |
• – – |
2007-12-05 |
4 |
OE |
$26.34 |
$1,009,380 |
D/D |
38,000 |
51,572 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP and CAO |
• – – |
2007-06-05 |
4 |
OE |
$26.70 |
$1,001,250 |
D/D |
37,500 |
60,072 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP and CAO |
• – – |
2007-06-05 |
4 |
AS |
$52.03 |
$1,951,125 |
D/D |
(37,500) |
22,572 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP and CAO |
• – – |
2007-03-12 |
4 |
OE |
$25.99 |
$998,290 |
D/D |
37,088 |
59,660 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP and CAO |
• – – |
2007-03-12 |
4 |
AS |
$43.27 |
$1,604,798 |
D/D |
(37,088) |
22,572 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP and CAO |
• – – |
2007-05-14 |
4 |
AS |
$48.06 |
$1,580,117 |
D/D |
(32,878) |
22,572 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP and CAO |
• – – |
2007-05-14 |
4 |
OE |
$26.70 |
$877,843 |
D/D |
32,878 |
55,450 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP, CAO and Acting CFO |
• – – |
2007-12-05 |
4 |
S |
$41.23 |
$1,263,358 |
D/D |
(30,600) |
28,072 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
CorpVP, Finance & Admin, CFO |
• – – |
2013-08-19 |
4 |
S |
$42.08 |
$1,262,295 |
D/D |
(30,000) |
72,669 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2010-11-03 |
4 |
OE |
$30.25 |
$889,078 |
D/D |
29,391 |
119,139 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2010-11-03 |
4 |
S |
$42.96 |
$1,262,584 |
D/D |
(29,391) |
89,748 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
• – – |
2010-12-16 |
4 |
D |
$47.84 |
$1,390,565 |
D/D |
(29,067) |
118,067 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
